Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATRA Atara Biotherapeutics

交易中 03-23 15:51:58 EDT

4.92

+0.01

+0.20%

最高5.03	最低4.76	成交量5.16万
今开5.00	昨收4.91	日振幅5.56%
总市值4,024万	流通市值2,755万	总股本817.81万
成交额25.28万	换手率0.92%	流通股本560.06万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATRA","market":"US","secType":"STK","nameCN":"Atara Biotherapeutics","latestPrice":4.92,"timestamp":1774295512747,"preClose":4.91,"halted":0,"volume":51614,"delay":0,"changeRate":0.0020366598778003638,"floatShares":5600599,"shares":8178114,"eps":2.57,"marketStatus":"交易中","change":0.01,"latestTime":"03-23 15:51:58 EDT","open":5,"high":5.0299,"low":4.7568,"amount":252770.28996419997,"amplitude":0.055621,"askPrice":4.95,"askSize":3,"bidPrice":4.9,"bidSize":9,"shortable":3,"etf":0,"ttmEps":2.57,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1413432000000,"exchange":"NASDAQ","adjPreClose":4.91,"preHourTrading":{"tag":"盘前","latestPrice":4.89,"preClose":4.91,"latestTime":"09:25 EDT","volume":4890,"amount":24092.677920000002,"timestamp":1774272348163,"change":-0.02,"changeRate":-0.004073,"amplitude":0.02444},"postHourTrading":{"tag":"盘后","latestPrice":4.91,"preClose":4.91,"latestTime":"19:48 EDT","volume":2443,"amount":12001.9333,"timestamp":1774050515709,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.317326,"impliedVol":0.0156,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ATRA","defaultTab":"news","newsList":[{"id":"2618378931","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨10.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618378931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618378931?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:31","pubTimestamp":1773063067,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日21时31分，Atara Biotherapeutics, Inc.股票出现异动，股价急速拉升10.06%。截至发稿，该股报5.69美元/股，成交量49.9921万股，换手率6.93%，振幅4.84%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Relmada Therapeutics, Inc.、Xenon制药、Dianthus Therapeutics, Inc.涨幅较大，Relmada Therapeutics, Inc.、Moolec Science Sa、Quince Therapeutics, Inc.较为活跃，换手率分别为29.80%、18.74%、13.13%，振幅较大的相关个股有Aditxt, Inc.、Uniqure N.V.、Edesa Biotech, Inc.，振幅分别为13.06%、10.58%、9.82%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309213107a6b2ab09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309213107a6b2ab09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2609519090","title":"Atara Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609519090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609519090?lang=zh_cn&edition=full","pubTime":"2026-02-06 23:33","pubTimestamp":1770392032,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日23时33分，Atara Biotherapeutics, Inc.股票出现波动，股价急速上涨5.10%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Engene Holdings Inc C/Wts 31/10/2028  Cl A、Bio Green Med Solution, Inc.、Decoy Therapeutics Inc.涨幅较大，Clearmind Medicine Inc.、Liminatus Pharma, Inc.、Ernexa Therapeutics Inc.较为活跃，换手率分别为444.27%、50.98%、24.05%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为59.58%、43.60%、41.54%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020623335297a53d0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020623335297a53d0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2607040846","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.26%报5.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607040846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607040846?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:59","pubTimestamp":1769785186,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日22时59分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅下跌5.26%。截至发稿，该股报5.22美元/股，成交量1.4633万股，换手率0.20%，振幅6.72%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Vivosim Labs, Inc.、Promis Neurosciences Inc.、Briacell Therapeutics Corp C/Wts 涨幅较大，Vivosim Labs, Inc.、Promis Neurosciences Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为1192.59%、293.29%、39.23%，振幅较大的相关个股有Promis Neurosciences Inc.、阿诺医药、Briacell Therapeutics Corp C/Wts ，振幅分别为37.98%、35.22%、31.63%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130225946a6c0c1aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130225946a6c0c1aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2605969844","title":"Atara Biotherapeutics, Inc.盘中异动 快速上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605969844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605969844?lang=zh_cn&edition=full","pubTime":"2026-01-22 01:26","pubTimestamp":1769016365,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日01时26分，Atara Biotherapeutics, Inc.股票出现波动，股价快速拉升5.56%。截至发稿，该股报4.56美元/股，成交量20.1337万股，换手率2.79%，振幅7.64%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Lisata Therapeutics, Inc.、Moolec Science Sa C/Wts 30/01/2028、Celularity Inc C/Wts 16/07/2026 涨幅较大，Aditxt, Inc.、Revelation Biosciences, Inc.、Lisata Therapeutics, Inc.较为活跃，换手率分别为1282.12%、83.29%、49.24%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Moolec Science Sa，振幅分别为71.60%、68.10%、66.06%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122012605a69d24a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122012605a69d24a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2603952653","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌7.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603952653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603952653?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:36","pubTimestamp":1768314998,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日22时36分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅下挫7.86%。截至发稿，该股报5.42美元/股，成交量26.9154万股，换手率3.73%，振幅9.52%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Decoy Therapeutics Inc.、Briacell Therapeutics Corp.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Scisparc Ltd.、Decoy Therapeutics Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为1092.01%、987.90%、246.32%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Decoy Therapeutics Inc.、Scisparc Ltd.，振幅分别为30.19%、29.45%、26.90%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113223638a4bf4e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113223638a4bf4e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"1104721374","title":"Atara Biotherapeutics股价盘前暴跌55%，美国FDA拒绝批准其血癌疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1104721374","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104721374?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:57","pubTimestamp":1768226268,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）拒绝批准Atara Biotherapeutics的血癌治疗方案，导致该公司股价在盘前交易时段大幅下挫55%。这一监管决定对该公司致力于推进肿瘤免疫疗法开发的努力构成重大打击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"1191179147","title":"Atara Biotherapeutics收到美国食品药品监督管理局完全回复函","url":"https://stock-news.laohu8.com/highlight/detail?id=1191179147","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191179147?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:04","pubTimestamp":1768223068,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics宣布，美国食品药品监督管理局（FDA）已针对其提交的申请文件发出完全回复函（CRL）。这一监管动态意味着该公司在相关审批流程中需根据FDA要求补充信息或进行额外调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2601185496","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨6.30%报18.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601185496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601185496?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:39","pubTimestamp":1767623950,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日22时39分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅上涨6.30%。截至发稿，该股报18.89美元/股，成交量2.1041万股，换手率0.29%，振幅2.76%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Gh Research Plc、Context Therapeutics Inc.涨幅较大，Can Fite Biopharma Ltd、Outlook Therapeutics, Inc.、Altimmune, Inc.较为活跃，换手率分别为630.72%、12.34%、11.30%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Newcelx Ltd.、Mereo Biopharma Group Plc，振幅分别为62.64%、22.46%、21.28%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223910a49f6a56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223910a49f6a56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2585147283","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.11%报13.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585147283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585147283?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:35","pubTimestamp":1763735749,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日22时35分，Atara Biotherapeutics, Inc.股票出现异动，股价急速上涨5.11%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。消息层面，截至22时35分，《瑞穗证券维持Atara Biotherapeutics买入评级，上调目标价至18美元》资讯为影响Atara Biotherapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212235499512de89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212235499512de89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2584095943","title":"Atara Biotherapeutics, Inc.2025财年第三财季实现净利润-4.30百万美元，同比增加80.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584095943","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584095943?lang=zh_cn&edition=full","pubTime":"2025-11-18 00:00","pubTimestamp":1763395227,"startTime":"0","endTime":"0","summary":"11月18日，Atara Biotherapeutics, Inc.公布财报，公告显示公司2025财年第三财季净利润为-4.30百万美元，同比增加80.37%；其中营业收入为3.45百万美元，同比减少91.42%，每股基本收益为-0.32美元。从资产负债表来看，Atara Biotherapeutics, Inc.总负债66.80百万美元，其中短期债务11.62百万美元，资产负债比为0.46，流动比率为1.03。机构评级：截至2025年11月18日，当前有3家机构对Atara Biotherapeutics, Inc.目标价做出预测，其中目标均价为16.33美元，其中最低目标价为16.00美元，最高目标价为17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118000040976f316c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118000040976f316c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA"],"gpt_icon":0},{"id":"1146174042","title":"Atara Biotherapeutics预计2025年全年运营费用将比2024年减少至少60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146174042","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146174042?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:05","pubTimestamp":1762956312,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics预计2025年全年运营费用将比2024年减少至少60%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2581012914","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨10.14%报11.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581012914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581012914?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:33","pubTimestamp":1762439585,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时33分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅拉升10.14%。截至发稿，该股报11.84美元/股，成交量1148股，换手率0.02%，振幅0.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Iovance Biotherapeutics, Inc.、Cytomed Therapeutics Limited、Pharming Group Nv涨幅较大，Osr Holdings, Inc.、Polyrizon Ltd.、Lunai Bioworks Inc.较为活跃，换手率分别为84.31%、11.27%、6.57%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Cartesian Therapeutics, Inc.、Sangamo Therapeutics, Inc.，振幅分别为20.60%、11.99%、11.78%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110622330594f38150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110622330594f38150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"1144783270","title":"Pierre Fabre Pharmaceuticals宣布从Atara Biotherapeutics转让Tabelecleucel治疗EB病毒阳性移植后淋巴增生性疾病的生物许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1144783270","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144783270?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:01","pubTimestamp":1762178505,"startTime":"0","endTime":"0","summary":"Pierre Fabre Pharmaceuticals宣布，从Atara Biotherapeutics转让Tabelecleucel用于治疗EB病毒阳性移植后淋巴增生性疾病（EBV+ PTLD）的生物许可申请（BLA）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2580421782","title":"Atara Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.84%报14.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580421782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580421782?lang=zh_cn&edition=full","pubTime":"2025-11-01 02:37","pubTimestamp":1761935853,"startTime":"0","endTime":"0","summary":"北京时间2025年11月01日02时37分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅上涨5.84%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，美第奇新星生物技术、Yd Bio Ltd C/Wts 28/08/2030、Rani Therapeutics Holdings, Inc.涨幅较大，Aditxt, Inc.、Intensity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1159.68%、375.54%、150.29%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为155.88%、141.46%、67.65%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110102373394e7d786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110102373394e7d786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2577846380","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577846380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577846380?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:49","pubTimestamp":1761054561,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时49分，Atara Biotherapeutics, Inc.股票出现异动，股价快速跳水6.36%。截至发稿，该股报15.02美元/股，成交量1904股，换手率0.03%，振幅1.81%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Minerva Neurosciences, Inc、Ibio, Inc.、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1019.01%、141.61%、35.12%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为139.02%、78.99%、47.03%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021214921973ac394&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021214921973ac394&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2570031444","title":"Atara Biotherapeutics, Inc.盘中异动 早盘急速上涨5.40%报13.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570031444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570031444?lang=zh_cn&edition=full","pubTime":"2025-09-24 21:45","pubTimestamp":1758721533,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日21时45分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅拉升5.40%。截至发稿，该股报13.67美元/股，成交量1.8392万股，换手率0.26%，振幅4.32%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Uniqure N.V.、Cyclerion Therapeutics, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Cyclerion Therapeutics, Inc.、Jaguar Health, Inc.、Uniqure N.V.较为活跃，换手率分别为350.72%、35.43%、30.19%，振幅较大的相关个股有Uniqure N.V.、Pharmacyte  Biotech, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为39.90%、28.69%、20.87%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092421453397a7244a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092421453397a7244a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2518158276","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌6.96%报6.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518158276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518158276?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:15","pubTimestamp":1741616103,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时15分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅下跌6.96%。截至发稿，该股报6.42美元/股，成交量2.6448万股，换手率0.46%，振幅8.48%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3311.53%、705.90%、399.10%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Trevi Therapeutics, Inc.，振幅分别为41.36%、40.24%、34.42%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221504964040be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221504964040be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2518030281","title":"Atara Biotherapeutics, Inc.2024财年实现净利润-85.40百万美元，同比增加69.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518030281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518030281?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536093,"startTime":"0","endTime":"0","summary":"3月10日，Atara Biotherapeutics, Inc.公布财报，公告显示公司2024财年净利润为-85.40百万美元，同比增加69.06%；其中营业收入为1.29亿美元，同比增加1405.25%，每股基本收益为-11.41美元。从资产负债表来看，Atara Biotherapeutics, Inc.总负债2.06亿美元，其中短期债务13.92百万美元，资产负债比为0.53，流动比率为48.07。机构评级：截至2025年3月10日，当前有5家机构对Atara Biotherapeutics, Inc.目标价做出预测，其中目标均价为12.00美元，其中最低目标价为5.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000334abf1759b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000334abf1759b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA"],"gpt_icon":0},{"id":"1109415107","title":"Atara Biotherapeutics 2024年第四季度GAAP每股收益$(1.19)优于预期$(3.58)，销售额$32.753M未达预期$19.148M","url":"https://stock-news.laohu8.com/highlight/detail?id=1109415107","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109415107?lang=zh_cn&edition=full","pubTime":"2025-03-08 05:08","pubTimestamp":1741381691,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics报告称，季度每股亏损$，优于分析师一致预期的$，提升了66.76%。公司报告季度销售额为$32.753M，未达到分析师一致预期的$19.148M，同比增长100%。相比去年同期的销售额$4.252M，这是一个100%的下降。以上内容来自Benzinga Earnings专栏，原文如下：$Atara Biotherapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 66.76 percent. This is a 91.5 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $32.753 which missed the analyst consensus estimate of $19.148 million by","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Atara Biotherapeutics 2024年第四季度GAAP每股收益$(1.19)优于预期$(3.58)，销售额$32.753M未达预期$19.148M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA"],"gpt_icon":0},{"id":"2517416646","title":"Atara Biotherapeutics, Inc.盘中异动 早盘大幅下挫5.61%报6.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517416646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517416646?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:50","pubTimestamp":1741272600,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时50分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅跳水5.61%。截至发稿，该股报6.90美元/股，成交量3249股，换手率0.06%，振幅2.87%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1340.52%、365.27%、62.94%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为33.60%、31.58%、28.10%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225000abeb7ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225000abeb7ced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atarabio.com","stockEarnings":[{"period":"1week","weight":-0.2446},{"period":"1month","weight":0.1084},{"period":"3month","weight":-0.714},{"period":"6month","weight":-0.5925},{"period":"1year","weight":-0.2715},{"period":"ytd","weight":-0.7286}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。该公司是T细胞免疫疗法的领导者，利用其新型同种异体EB病毒（EBV）T细胞平台为癌症和自身免疫性疾病患者开发转化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.013345},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.053974},{"month":3,"riseRate":0.416667,"avgChangeRate":0.032334},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.039343},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.070861},{"month":6,"riseRate":0.636364,"avgChangeRate":0.068043},{"month":7,"riseRate":0.636364,"avgChangeRate":0.002868},{"month":8,"riseRate":0.545455,"avgChangeRate":-0.029857},{"month":9,"riseRate":0.727273,"avgChangeRate":0.031685},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.093327},{"month":11,"riseRate":0.833333,"avgChangeRate":0.232545},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.068414}],"exchange":"NASDAQ","name":"Atara Biotherapeutics","nameEN":"Atara Biotherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atara Biotherapeutics,ATRA,Atara Biotherapeutics股票,Atara Biotherapeutics股票老虎,Atara Biotherapeutics股票老虎国际,Atara Biotherapeutics行情,Atara Biotherapeutics股票行情,Atara Biotherapeutics股价,Atara Biotherapeutics股市,Atara Biotherapeutics股票价格,Atara Biotherapeutics股票交易,Atara Biotherapeutics股票购买,Atara Biotherapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}